As the most reliable and balanced news aggregation service on the internet, DML News offers the following information published by TIME.COM:
A clinical trial that involved giving sildenafil, a drug typically used to treat erectile dysfunction, to expecting mothers has been been immediately halted after 11 newborn babies died.
The Dutch study was examining the possible benefits of the medication, which increases blood flow, on improving the growth of fetuses in mothers with poorly developed placentas, Reuters reports. But the drug may have resulted in lethal damage to the babies’ lungs.
The article goes on to state the following:
The trial, which began in 2015, involved 11 hospitals and 183 women.
Among the treatment group, 17 babies developed lung conditions that reportedly caused high blood pressure in the lungs and may have been the result of reduced oxygen levels. Eleven of these newborns died.
In the control group, three newborns developed lung conditions, and none died.
The researchers found no positive effect of the drug, the Amsterdam University’s Academic Medical Center (AMC) said.
Sildenafil is the active ingredient in popular erectile dysfunction medications like Viagra, but the study did not involve Viagra nor a generic form authorized by Viagra’s creator, Pfizer.
Underdeveloped placentas can led to fetal growth restriction, a serious condition that can result in premature births, low birth weights and death. There is currently no treatment.
To weigh in on this information provided by TIME.COM, engage in our LIVE CHAT below. Scroll down.